from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2824c/-

LFCtreatmentdescriptionclass of inhibitor

-0.354

Amikacinug/mL Amikacintranslation

-1.129

Cap5-10ug/mL Capreomycintranslation

0.323

Rox10-50 ug/mL Roxithromycintranslation

-0.239

SM2-5 ug/mL Streptomycintranslation

-0.326

Tet5-10 ug/mL Tetracyclinetranslation

0.401

Rif0.2-5ug/mL Rifampicintranscription

0.425

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.339

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.155

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.321

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.077

Clofazimine10-13 ug/mL Clofaziminerespiration

-1.233

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.677

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.511

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.583

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.590

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.140

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.299

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.027

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.219

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.206

Nigericin50 uM Nigericinrespiration

0.344

TRC10-150 ug/mL Triclosanrespiration

0.089

TRZ10-25 ug/mL Thioridazinerespiration

1.906

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.265

menadione6-10 ug/mL Menadionerespiration

-0.092

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.444

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.129

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.567

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.591

NRP_1Non-replicating persistence stage 1dosRassociated

-0.531

Amp0.2mg/mL AmpicillincellWall

-0.479

Cephalexin20-100 ug/mL CephalexincellWall

0.492

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.805

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.346

EMB10-20 ug/mL EthambutolcellWall

-0.425

Eta12-40 ug/mL EthionamidecellWall

-0.653

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.189

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.491

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.328

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.167

BZA0.12 mg/mL BenzamidearomaticAmides

-0.170

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.313

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.354

H2O24 mM hydrogen peroxideDNAdamaging

0.068

Levo10 ug/mL LevofloxacinDNAdamaging

-0.445

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.729

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.025

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.038

UVUV-irradiationDNAdamaging

-0.297

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.314

Antimycin12.5-50 ug/mL Antimycin A?

-0.451

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.302

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.309

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.297

PA8240.2-2 ug/mL PA-824?

1.911

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.164

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.320

Verapamil50 uM Verapamil?

0.000

mercaptoethanol2 mM 2-Mercaptoethanol?

1.114

methoxatin10-20 ug/mL Methoxatin?